<DOC>
	<DOCNO>NCT00151437</DOCNO>
	<brief_summary>The purpose study : 1 ) provide SOMAVERT compassionate use patient acromegaly complete clinical trial responsive , 2 ) evaluate safety tolerability SOMAVERT .</brief_summary>
	<brief_title>Canadian Pegvisomant Compassionate Study In Acromegalic Patients</brief_title>
	<detailed_description />
	<mesh_term>Acromegaly</mesh_term>
	<criteria>Subjects must participate complete previous Pegvisomant study show unresponsive conventional therapy ALT/AST &gt; 3 time ULN hepatic disease severe visual field loss , cranial nerve palsy intracranial HTN require surgery decompress tumor unwilling selfadminister medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>